Camlin Fine Sciences Ltd (CAMLINFINE) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532834 | NSE: CAMLINFINE | Chemicals | Small Cap

Camlin Fine Sciences Share Price

149.70 -5.50 -3.54%
as on 05-Dec'25 15:23

Camlin Fine Sciences Ltd (CAMLINFINE) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532834 | NSE: CAMLINFINE | Chemicals | Small Cap

DeciZen - make an informed investing decision on Camlin Fine Sciences

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Camlin Fine Sciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
2,981.2 Cr.
52-wk low:
110.4
52-wk high:
334.7

Is Camlin Fine Sciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Camlin Fine Sciences: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Camlin Fine Sciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 22%7.4%1.7%6.2%10.6%6.9%7.7%11.3%0.2%-3.9%-
Value Creation
Index
0.6-0.5-0.9-0.6-0.2-0.5-0.5-0.2-1.0-1.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 412325403548580600686789773886913
Sales YoY Gr.--21.2%24.1%36.1%5.8%3.5%14.2%15.2%-2.1%14.6%-
Adj EPS 2.80.2-1.30.71.61.11.21.9-3.1-0.7-0.2
YoY Gr.--93.6%-816.7%NA129.6%-32.5%10%59.5%-261.7%NA-
BVPS (₹) 12.216.424.926.230.331.736.13940.945.149.3
Adj Net
Profit
27.71.9-16.18.820.214.419.431.1-53.6-13.9-4
Cash Flow from Ops. 50.9-30.1-5.2-44.673.92646.818.582.121.9-
Debt/CF from Ops. 3.1-8.1-41.7-74.514.39.632.6620.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8.9%8.9%9%14.6%
Adj EPS -186.3%-185.4%-184.9%NA
BVPS15.6%8.3%7.7%10.2%
Share Price 4.2% 4.4% -0.6% 25.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
25.41.3-6.32.65.63.43.75-7.9-1.8-0.5
Op. Profit
Mgn %
16.58.51.1610.412.411.616.84.38.98
Net Profit
Mgn %
6.70.6-41.63.52.42.83.9-6.9-1.6-0.5
Debt to
Equity
1.31.40.710.90.90.810.70.50.2
Working Cap
Days
232322338305315338344366415348159
Cash Conv.
Cycle
9618118015216216816519323317061

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Camlin Fine Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) -0.2 -1.5
TTM Sales (₹ Cr.) 913 1,754
BVPS (₹.) 49.3 51.6
Reserves (₹ Cr.) 927 972
P/BV 3.15 3.01
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 110.39 / 334.70
All Time Low / High (₹) 1.90 / 334.70
Market Cap (₹ Cr.) 2,981
Equity (₹ Cr.) 19.2
Face Value (₹) 1
Industry PE 48.1

Management X-Ray of Camlin Fine Sciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.0012.4312.4312.4312.4310.840.0010.84
* Pledged shares as % of Promoter's holding (%)

Valuation of Camlin Fine Sciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Camlin Fine Sciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales412325403548580600686789773886
Operating Expenses 345301399515519534606657741807
Manufacturing Costs37293442506496157169184
Material Costs244204303409389378395366444481
Employee Cost 19222123283953606672
Other Costs 44474142525463756270
Operating Profit 68234336066791323379
Operating Profit Margin (%) 16.4%7.2%1.0%6.0%10.4%10.9%11.6%16.8%4.2%8.9%
Other Income 414131427820292121
Interest 22262623313836626275
Depreciation 101299111927334953
Exceptional Items -5000-3-100-2-96
Profit Before Tax 350-181441153667-60-123
Tax 91-431171019-8-47
Profit After Tax 26-1-14113182648-51-76
PAT Margin (%) 6.2%-0.2%-3.5%2.0%5.3%1.4%3.8%6.0%-6.6%-8.6%
Adjusted EPS (₹)2.6-0.1-1.10.92.50.61.63.0-3.0-4.1
Dividend Payout Ratio (%)17%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 121174309325376413580628702848
Share Capital 10101212121316161719
Reserves 111164297313364400564612685829
Minority Interest0000000000
Debt146234215310331363438512456393
Long Term Debt201114111113163258292222172
Short Term Debt126223200199218201180220233221
Trade Payables8036114106133193212249284268
Others Liabilities 36293839519711620513077
Total Liabilities 3824746767808911,0671,3461,5941,5721,586

Fixed Assets

Gross Block1608890109131348381682723765
Accumulated Depreciation7111202937567799147198
Net Fixed Assets 8976708094292304583577567
CWIP 11420681981820728319
Investments 744148697474828280102
Inventories11811611510997131142252255263
Trade Receivables98131211262323368441526492414
Cash Equivalents 13131169138256101485
Others Assets 557810112292102113113123147
Total Assets 3824746767808911,0671,3461,5941,5721,586

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 51-30-5-45742647198222
PBT 350-181441153667-60-123
Adjustment 3329191922655576144177
Changes in Working Capital -11-52-6-7412-44-43-11716-30
Tax Paid -6-7-0-4-1-10-1-7-18-1
Cash Flow From Investing Activity -49-31-116-3-66-88-172-115-52-88
Capex -37-6-15-52-115-39-189-131-41-22
Net Investments -2-26-1024344-502829-8-65
Others -1021552-11-12-3-1
Cash Flow From Financing Activity -16112065-268012978-34101
Net Proceeds from Shares 358148000111223
Net Proceeds from Borrowing 0-14-2-10-2468891-1-48
Interest Paid -22-23-24-31-39-40-31-39-47-54
Dividend Paid -4-500000000
Others 2245-21061674712613-21
Net Cash Flow 00-117-18183-18-435

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)23.55-0.54-5.873.388.762.15.217.87-7.73-9.85
ROCE (%)22.047.361.656.1910.596.97.7211.280.18-3.85
Asset Turnover Ratio1.160.790.70.750.690.610.570.540.490.56
PAT to CFO Conversion(x)1.96N/AN/A-4.092.393.251.810.4N/AN/A
Working Capital Days
Receivable Days96124154158184210215224240187
Inventory Days901271047565707391120107
Payable Days1291049198112157187230219209

Camlin Fine Sciences Ltd Stock News

Camlin Fine Sciences Ltd FAQs

The current trading price of Camlin Fine Sciences on 05-Dec-2025 15:23 is ₹149.7.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Camlin Fine Sciences stood at ₹2,981.2.
The latest P/E ratio of Camlin Fine Sciences as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Camlin Fine Sciences as of 04-Dec-2025 is 3.15.
The 52-week high of Camlin Fine Sciences is ₹334.7 and the 52-week low is ₹110.4.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Camlin Fine Sciences is ₹913.1 ( Cr.) .

About Camlin Fine Sciences Ltd

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956. In 2011
Company changed its name from Camlin Fine Chemicals Ltd. to Camlin Fine Sciences Ltd. 

Camlin Fine Chemicals is the world's second largest manufacturer and marketer of food grade antioxidants TBHQ and BHA. Its mission is to be the largest food antioxidant and ingredient manufacturer worldwide. Their facilities are HACCP and ISO 9001 : 2000 certified.

Product Range:

a) Food Ingredients –

Antox TBHQ (HACCP Certified) FCC V / FAO / WHO (Tertiary Butyl Hydroquinone)

Antox BHA (HACCP Certified) FCC V / FAO / WHO / EEC ( Butyl Hydroxy Anisole)

b) Sweetener -

Sucralose FCC V

c) Active Pharmaceutical Ingredients -

  • Miconazole Nitrate B.P. / USP
  • Clotrimazole B.P. / USP
  • Amlodipine Besilate E.P
  • Amlodipine Salts
  • Advance intermediate of Amlodipine
  • Intermediate of Miconazole Nitrate

d) Super Absorbent Polymer

Subsidiary Details:

  • Chemolutions Chemicals: Specialty Chemical Intermediates
  • Sangam Laboratories: Nutraceuticals
  • Fine Renewable Energy.
  • Fine LifeStyle Brands: Luxury Fashion Brands

On 6th June 2008 - The company entered into a joint venture, on 51:49 basis, with US based Viachem LLC, to set up a joint venture company under the name Dulcette Technologies for marketing Sucralose, Aspartame, and Acesulfame-K, and their belnds in USA, Canada, and Maxico.

On 7th July 2008 - The Board of Directors of the company at its meeting held on 29th July 2008, approved the proposal for setting up a joint venture company with Pagoda Advisors and their associates.

As per the deal, Camlin Fine Chemicals will get 51% of the equity of the proposed new company and the rest 49% will be owned by Pagoda Advisors and their associates.The proposed new company will focus on the retail of luxury/premium brands in India by setting up stores in all stores in all major metros and cities in India by itself and through franchisees.

On 25th February 2008:  Camlin Fine Chemicals acquired 60% equity stake in Sangam Laboratories, a Small Scale Unit manufacturing Nutraceuticals and Drug Intermediates at Tarapur.

On 12th February 2008 - The company inked a joint venture deal with US based Advanced Aerospace Technologies to manufacture and market speciality fine chemicals primarily to cater to European and U.S markets.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×